Karine Fabienne Malagu

This inventor holds 25 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Usher III Initiative, Inc., Galapagos Nv, Enyo Pharma. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karine Fabienne Malagu. Retrieved from https://idiyas.com/inventor/karine-fabienne-malagu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 9.1

ph-index = 4

Forward Citations = 66(Granted Patents)

Location History:

Saffron, GB (2019)
Saffron Walden, GB (2014 - 2023)
Cambridge, GB (2022 - 2023)

Company Filing History:

9 out of 10

Usher III Initiative, Inc.

Chdi Foundation, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

HTT Modulators

Huntington's Disease

Thiophene Derivatives

Antiviral Agents

Cystic Fibrosis

Transmembrane Conductance Regulator

Pyrazolopyridazines

Retinal Degenerative Diseases

Hearing Loss

Usher Syndrome

Fused Thiophene

Non-fused Thiophene

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281116 - HTT modulators for treating Huntington's disease (2025-04-21),

2. 11840527 - Non-fused thiophene derivatives and their uses (2023-12-12),

3. 11807618 - Thiophene derivatives as antiviral agents (2023-11-07),

4. 11806346 - HTT modulators for treating Huntington's disease (2023-11-07),

5. 11767316 - Non-fused thiophene derivatives and their uses (2023-09-26),

6. 11603368 - Fused thiophene derivatives and their uses (2023-03-14),

7. 11492347 - Fused thiophene derivatives and their uses (2022-11-08),

8. 11279683 - Thiophene derivatives as antiviral agents (2022-03-22),

9. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-27),

10. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-20),

11. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

12. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

13. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-10),

14. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2019-10-01),

15. 10307422 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2019-06-04),

Title: Innovator Spotlight: Karine Fabienne Malagu

Introduction

Karine Fabienne Malagu, based in Saffron Walden, GB, is an accomplished inventor with a substantial portfolio of 24 patents. Her groundbreaking work primarily focuses on developing innovative pharmaceutical compounds that address various medical challenges.

Latest Patents

Among her most recent innovations are two significant patents. The first, titled "Non-fused thiophene derivatives and their uses," introduces a new class of non-fused thiophene derivatives designed for treating various diseases, including infections, cancer, metabolic disorders, cardiovascular diseases, iron storage disorders, and inflammatory conditions. The second patent, "Thiophene derivatives as antiviral agents," highlights a novel class of compounds with notable antiviral effects, further demonstrating her expertise in medicinal chemistry and pharmacology.

Career Highlights

Throughout her career, Karine has made impressive contributions to the field of pharmaceuticals. She has worked with notable companies, including the Usher III Initiative, Inc. and Galapagos N.V., where she has played a key role in advancing innovative treatments.

Collaborations

Karine has collaborated with esteemed professionals in her field, including Roland Werner Bürli and Christopher James Lock. Together, they have contributed to expanding the frontiers of medical research and the development of therapeutic applications.

Conclusion

Karine Fabienne Malagu stands out as a notable inventor whose contributions are advancing the realms of medicine and pharmacology. Her patents not only signify innovation but also signify hope for treatments of challenging medical conditions.

Profile summary based on public USPTO records.